Effect of lowering HBV DNA levels by initial antiviral therapy before adding immunomodulator on treatment of chronic hepatitis B.
Sarin SK, Sood A, Kumar M, Arora A, Amrapurkar D, Sharma BC, Konar A, Chawla YK, Jain RK, Nanda V, Kumar A, Hissar S, Lavate P, Lahoti D; National Collaborative Group on Hepatitis B, India.
Sarin SK, et al. Among authors: kumar a, kumar m.
Am J Gastroenterol. 2007 Jan;102(1):96-104. doi: 10.1111/j.1572-0241.2006.01006.x.
Am J Gastroenterol. 2007.
PMID: 17266689